These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 10202440)

  • 1. [Carriers of Staphylococcus aureus as a source of nosocomial infections. Epidemiological and prophylactic aspects].
    Kolmos HJ
    Ugeskr Laeger; 1999 Mar; 161(11):1580-4. PubMed ID: 10202440
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Preventing postoperative Staphylococcus infections: an update.
    Grady M; Cullen JJ
    Surg Technol Int; 2003; 11():57-60. PubMed ID: 12931284
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Use of nasal mupirocin for Staphylococcus aureus: effect on nasal carriers and nosocomial infections].
    García AM; Villa MV; Escudero ME; Gómez P; Vélez MM; Múnera MI; Franco G
    Biomedica; 2003 Jun; 23(2):173-9. PubMed ID: 12872556
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Nasal carriage of meticillin resistant Staphylococcus aureus: the prevalence, patients at risk and the effect of elimination on outcomes among outclinic haemodialysis patients.
    Lederer SR; Riedelsdorf G; Schiffl H
    Eur J Med Res; 2007 Jul; 12(7):284-8. PubMed ID: 17933699
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Nasal carriage of Staphylococcus aureus and prevention of nosocomial infections.
    Kluytmans JA; Wertheim HF
    Infection; 2005 Feb; 33(1):3-8. PubMed ID: 15750752
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Intranasal mupirocin to prevent postoperative Staphylococcus aureus infections.
    Perl TM; Cullen JJ; Wenzel RP; Zimmerman MB; Pfaller MA; Sheppard D; Twombley J; French PP; Herwaldt LA;
    N Engl J Med; 2002 Jun; 346(24):1871-7. PubMed ID: 12063371
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Safety of targeted perioperative mupirocin treatment for preventing infections after cardiac surgery.
    Shrestha NK; Banbury MK; Weber M; Cwynar RE; Lober C; Procop GW; Karafa MT; Gordon SM
    Ann Thorac Surg; 2006 Jun; 81(6):2183-8. PubMed ID: 16731151
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Routine use of mupirocin at the peritoneal catheter exit site and mupirocin resistance: still low after 7 years.
    Lobbedez T; Gardam M; Dedier H; Burdzy D; Chu M; Izatt S; Bargman JM; Jassal SV; Vas S; Brunton J; Oreopoulos DG
    Nephrol Dial Transplant; 2004 Dec; 19(12):3140-3. PubMed ID: 15466881
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Staphylococcus aureus infection in haemodialysis patients. Mupirocin as a topical strategy against nasal carriage: a review.
    Boelaert JR
    J Chemother; 1994 Apr; 6 Suppl 2():19-24. PubMed ID: 7799051
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Impact of preoperative screening for meticillin-resistant Staphylococcus aureus by real-time polymerase chain reaction in patients undergoing cardiac surgery.
    Jog S; Cunningham R; Cooper S; Wallis M; Marchbank A; Vasco-Knight P; Jenks PJ
    J Hosp Infect; 2008 Jun; 69(2):124-30. PubMed ID: 18387695
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Preoperative risk factors for postoperative Staphylococcus aureus nosocomial infections.
    Fang S; Skeete D; Cullen JJ
    Surg Technol Int; 2004; 13():35-8. PubMed ID: 15744674
    [TBL] [Abstract][Full Text] [Related]  

  • 12. An integrated critique of the efficacy of topical mupirocin in preventing catheter-related Staphylococcus aureus infections in peritoneal dialysis clients.
    Pratt O
    CANNT J; 2002; 12(1):20-8. PubMed ID: 11979650
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Treatment of Staphylococcus aureus colonization and prophylaxis for infection with topical intranasal mupirocin: an evidence-based review.
    Laupland KB; Conly JM
    Clin Infect Dis; 2003 Oct; 37(7):933-8. PubMed ID: 13130405
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prevention of Staphylococcus aureus burn wound colonization by nasal mupirocin.
    Kooistra-Smid AM; van Zanten E; Ott A; van Dijk SR; Beerthuizen GI; Vogels WH; van Belkum A; Verbrugh HA
    Burns; 2008 Sep; 34(6):835-9. PubMed ID: 18242873
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mupirocin to prevent S. aureus infections.
    Farr BM
    N Engl J Med; 2002 Jun; 346(24):1905-6. PubMed ID: 12063377
    [No Abstract]   [Full Text] [Related]  

  • 16. Controlling the usage of intranasal mupirocin does impact the rate of Staphylococcus aureus deep sternal wound infections in cardiac surgery patients.
    Nicholson MR; Huesman LA
    Am J Infect Control; 2006 Feb; 34(1):44-8. PubMed ID: 16443093
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Control of a methicillin-resistant Staphylococcus aureus outbreak in a neonatal intensive care unit by unselective use of nasal mupirocin ointment.
    Hitomi S; Kubota M; Mori N; Baba S; Yano H; Okuzumi K; Kimura S
    J Hosp Infect; 2000 Oct; 46(2):123-9. PubMed ID: 11049705
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Preoperative risk factors for nasal carriage of Staphylococcus aureus.
    Herwaldt LA; Cullen JJ; French P; Hu J; Pfaller MA; Wenzel RP; Perl TM
    Infect Control Hosp Epidemiol; 2004 Jun; 25(6):481-4. PubMed ID: 15242196
    [TBL] [Abstract][Full Text] [Related]  

  • 19. New approaches to prevention of staphylococcal infection in surgery.
    van Rijen MM; Kluytmans JA
    Curr Opin Infect Dis; 2008 Aug; 21(4):380-4. PubMed ID: 18594290
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Intranasal mupirocin to prevent postoperative infections.
    von Eiff C; Kipp F; Becker K
    N Engl J Med; 2002 Oct; 347(15):1207-8; author reply 1207-8. PubMed ID: 12374887
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.